
A partnership between @HHS_Health, @ASNKidney, and private sector to accelerate treatment options for #kidneydiseases. Tweets from ASN staff.
Joined January 2018
- Tweets1.4K
- Following61
- Followers3.1K
- Likes833
KidneyX retweeted
📣 KidneyCure grant applications are open. Access funding that can be instrumental in your career and help advance kidney care.
Apply by Thursday, Nov. 19, at 2:00 p.m. EST: bit.ly/kcgrantsfunding
Questions? Join the webinar Thursday, Oct. 29, at 12:00 p.m. EDT: bit.ly/grantsweb
Missed the KidneyX EMPOWER Prize Showcase last week? The innovation is still on display. 💡
Catch up on the showcase and hear directly from this year's nine prize winners here: healthit.gov/event/advancing…
KidneyX EMPOWER Prize Winner "Expanding Living Kidney Donation in Adults in Adults 65 and Older" developed by @MedStarGUH Transplant Institute, replaces fixed criteria with an individualized, age-adjusted, and risk-stratified evaluation framework.
KidneyX EMPOWER Winner "Cadence" developed by @nyulangone, is a virtual program employing trained lay navigators to deliver the "Live Donor Champion" program, equipping families to act as advocates. They are seeking donor community partners!
KidneyX Empower Prize Winner DonorForward developed by Columbia University Irving Medical Center/@nyphospital is a structured identification and decision aid system turning unused donor readiness into non-directed kidney transplants!
Dhiren Kumar, MD with @VCUHealth School of Medicine presents KidneyX Empower Prize Winner "The KHCP Living Link Pathway". The KHCP Living Link Pathway is an EHR-enabled care model that uses rule-based CKD identification and predictive risk equations to activate donors early.
Kelsey Drewry, PhD, presents KidneyX Empower Prize Winner LIVINGKidney. Developed by @Regenstrief, LIVINGKidney is a standalone mobile app and website that provides structured guidance and AI knowledge assistance for living donors!
.@ASNKidney President @samirparikhmd helps kick off the KidneyX EMPOWER Prize Showcase. "The winning technologies, prototypes, and clinical innovations will transform the experience of becoming a living donor, being a living donor, and caring for living donors".
Join @ASNKidney, @ONC_HealthIT, and the kidney community this morning from 9:00 a.m.–12:00 p.m. EDT as the winners of the #KidneyX EMPOWER Prize Challenge present their innovations! Tune in to the showcase here: hhs.gov/live/index.html
The 2026 #KidneyX EMPOWER prize winners will present their innovations tomorrow, September 10, in Washington, DC! Join @ASNKidney, HHS, and the kidney community in celebrating the winning solutions. The showcase will be livestreamed at 9:00 a.m. EDT: hhs.gov/live/index.html
Join us on September 10 from 9:00 a.m.–12:00 p.m. EDT (registration 8:30) for the KidneyX EMPOWER Winners Showcase! Hear from the innovators working to advance living kidney donation. Registration for in-person attendance ends September 5. More info here: healthit.gov/event/advancing…
HHS has announced the nine winners of the 2026 #KidneyX Empower: Living Link Prize Challenge. The competition sought innovations to improve the process of living kidney donation. Read all about the winning solutions here: hhs.gov/press-room/hhs-annou…
KidneyX retweeted
Innovation Highlight 🔦: We are seeking tools for "Donor-Centered Outcomes." How can technology better support a living donor's journey? Show us your solution. Submit to Track B of the KidneyX EMPOWER Prize today. kidneyxempowerchallenge.org/ #KidneyX @ASNKidney
The KidneyX EMPOWER Challenge closes in 10 days. Turn ideas into action and bring forward a solution that can advance living kidney donation.
🏆Four Million in prizes
🔀 Two participation paths
💡 Five focus areas
Submit by Mon, June 15, at 5 p.m. PDT: bit.ly/26empower
KidneyX retweeted
Innovation Highlight 🔦: We are seeking tools for "Donor-Centered Outcomes." How can technology better support a living donor's journey? Show us your solution. Submit to Track B of the KidneyX EMPOWER Prize today. kidneyxempowerchallenge.org/ #KidneyX @ASNKidney













